Sarvesh Sabarathinam , Sanjana Satheesh , Arun Raja
{"title":"Plant-based medicines in the treatment of cardiometabolic disorders: A special view on sarcopenic obesity","authors":"Sarvesh Sabarathinam , Sanjana Satheesh , Arun Raja","doi":"10.1016/j.obmed.2023.100497","DOIUrl":null,"url":null,"abstract":"<div><p>The incidence and prevalence of obesity-mediated cardiometabolic complications are increasing gradually worldwide. In the elderly population, sarcopenic obesity<span> causes significant changes in glucose and lipid metabolism<span>, increasing morbidity and mortality rates. Early assessment and strategic treatment patterns for sarcopenic obesity is crucial in preventing the development and worsening of metabolic conditions like diabetes, renal, hepatic complications, cardiovascular dysfunction, etc. Plant-derived medicines have a long history of use in various chronic complications. Since the majority of the patient believe alternative therapies are inherently safe. Existing preclinical and clinical studies ensure that most bioactive compounds play a significant role in glucose and lipid homeostasis.</span></span></p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451847623000210","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2
Abstract
The incidence and prevalence of obesity-mediated cardiometabolic complications are increasing gradually worldwide. In the elderly population, sarcopenic obesity causes significant changes in glucose and lipid metabolism, increasing morbidity and mortality rates. Early assessment and strategic treatment patterns for sarcopenic obesity is crucial in preventing the development and worsening of metabolic conditions like diabetes, renal, hepatic complications, cardiovascular dysfunction, etc. Plant-derived medicines have a long history of use in various chronic complications. Since the majority of the patient believe alternative therapies are inherently safe. Existing preclinical and clinical studies ensure that most bioactive compounds play a significant role in glucose and lipid homeostasis.
Obesity MedicineMedicine-Public Health, Environmental and Occupational Health
CiteScore
5.50
自引率
0.00%
发文量
74
审稿时长
40 days
期刊介绍：
The official journal of the Shanghai Diabetes Institute Obesity is a disease of increasing global prevalence with serious effects on both the individual and society. Obesity Medicine focusses on health and disease, relating to the very broad spectrum of research in and impacting on humans. It is an interdisciplinary journal that addresses mechanisms of disease, epidemiology and co-morbidities. Obesity Medicine encompasses medical, societal, socioeconomic as well as preventive aspects of obesity and is aimed at researchers, practitioners and educators alike.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
